Orthocell soars 356% on test results

08/05/2019 - 12:24

Bookmark

Save articles for future reference.

Shares in Perth biotech Orthocell more than quadrupled in value today after the company released positive results from a trial of its nerve regeneration product.

This article is only available to our paid subscribers.

To read this article and get full access to every insight Business News offers, subscribe today.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options